These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 33676593)

  • 21. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.
    Gao M; Piernas C; Astbury NM; Hippisley-Cox J; O'Rahilly S; Aveyard P; Jebb SA
    Lancet Diabetes Endocrinol; 2021 Jun; 9(6):350-359. PubMed ID: 33932335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.
    Vollmer WM; Peters D; Crane B; Kelleher C; Buist AS
    COPD; 2007 Jun; 4(2):135-42. PubMed ID: 17530507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study.
    Bloom CI; Cullinan P; Wedzicha JA
    Am J Respir Crit Care Med; 2022 Jan; 205(1):36-45. PubMed ID: 34669568
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Nannini LJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD006829. PubMed ID: 22972099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases.
    Liao SY; Petrache I; Fingerlin TE; Maier LA
    Respir Med; 2021 Jan; 176():106275. PubMed ID: 33276252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort.
    Yates T; Zaccardi F; Islam N; Razieh C; Gillies CL; Lawson CA; Chudasama Y; Rowlands A; Davies MJ; Docherty AB; Openshaw PJM; Baillie JK; Semple MG; Khunti K
    BMC Infect Dis; 2021 Jul; 21(1):717. PubMed ID: 34330226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
    Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.
    Short PM; Williamson PA; Elder DHJ; Lipworth SIW; Schembri S; Lipworth BJ
    Chest; 2012 Jan; 141(1):81-86. PubMed ID: 21799028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Impact of preventive treatment with long-acting beta(2)-adrenergic agonists and inhaled corticosteroids on the morbidity and mortality of severe asthma exacerbations in 1543 patients].
    Plaza V; Bellido-Casado J; Rodrigo GJ; Solarte I; Rodríguez-Trigo G; Sepúlveda R; Neffen H; Perpiñá M
    Arch Bronconeumol; 2009 Nov; 45(11):545-9. PubMed ID: 19651467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of cardiovascular events following COVID-19 in people with and without pre-existing chronic respiratory disease.
    Whittaker H; Kallis C; Bolton T; Wood A; Walker S; Sheikh A; Brownrigg A; Akbari A; Sterniczuk K; Quint JK;
    Int J Epidemiol; 2024 Apr; 53(3):. PubMed ID: 38850276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β
    Wang MT; Lai JH; Huang YL; Liou JT; Cheng SH; Lin CW; Pan HY; Hsu YJ; Tsai CL
    Chest; 2021 Oct; 160(4):1255-1270. PubMed ID: 34023320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-hospital use of inhaled corticosteroids and inhaled beta agonists and incidence of ARDS: A population-based study.
    Mangi AM; Bansal V; Li G; Pieper MS; Gajic O; Festic E
    Acta Med Acad; 2015; 44(2):109-16. PubMed ID: 26702906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.
    Gonçalves BP; Hall M; Jassat W; Balan V; Murthy S; Kartsonaki C; Semple MG; Rojek A; Baruch J; Reyes LF; Dasgupta A; Dunning J; Citarella BW; Pritchard M; Martín-Quiros A; Sili U; Baillie JK; Aryal D; Arabi Y; Rashan A; Angheben A; Caoili J; Carrier FM; Harrison EM; Gómez-Junyent J; Figueiredo-Mello C; Douglas JJ; Mat Nor MB; Chow YP; Wong XC; Bertagnolio S; Thwin SS; Streinu-Cercel A; Salazar L; Rishu A; Rangappa R; Ong DSY; Hashmi M; Carson G; Diaz J; Fowler R; Kraemer MUG; Wils EJ; Horby P; Merson L; Olliaro PL;
    Elife; 2022 Oct; 11():. PubMed ID: 36197074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020.
    Dennis JM; Mateen BA; Sonabend R; Thomas NJ; Patel KA; Hattersley AT; Denaxas S; McGovern AP; Vollmer SJ
    Diabetes Care; 2021 Jan; 44(1):50-57. PubMed ID: 33097559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
    Chong J; Karner C; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009157. PubMed ID: 22972134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
    Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
    Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination inhaled steroid and long-acting beta₂-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease.
    Rojas-Reyes MX; García Morales OM; Dennis RJ; Karner C
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD008532. PubMed ID: 27271056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and Ontario.
    Matthewman J; Tadrous M; Mansfield KE; Thiruchelvam D; Redelmeier DA; Cheung AM; Lega IC; Prieto-Alhambra D; Cunliffe LA; Mulick A; Henderson A; Langan SM; Drucker AM
    JAMA Dermatol; 2023 Sep; 159(9):961-969. PubMed ID: 37556153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.